GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MedCap AB (OSTO:MCAP) » Definitions » Median PS Value

MedCap AB (OSTO:MCAP) Median PS Value : kr312.06 (As of Mar. 27, 2025)


View and export this data going back to 2004. Start your Free Trial

What is MedCap AB Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. MedCap AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr121.13. MedCap AB's 10-Year median PS Ratio is 2.5762. Therefore, the Median PS Value for today is kr312.06.

As of today (2025-03-27), MedCap AB's share price is kr340.00. MedCap AB's Median PS Value is kr312.06. Therefore, MedCap AB's Price to Median PS Value for today is 1.09.

The historical rank and industry rank for MedCap AB's Median PS Value or its related term are showing as below:

OSTO:MCAP' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.09   Med: 2.56   Max: 5.94
Current: 1.09

During the past 13 years, the highest Price to Median PS Value of MedCap AB was 5.94. The lowest was 1.09. And the median was 2.56.

OSTO:MCAP's Price-to-Median-PS-Value is ranked worse than
75.48% of 314 companies
in the Medical Devices & Instruments industry
Industry Median: 0.765 vs OSTO:MCAP: 1.09

MedCap AB Median PS Value Historical Data

The historical data trend for MedCap AB's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCap AB Median PS Value Chart

MedCap AB Annual Data
Trend Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.72 48.13 84.44 168.29 312.06

MedCap AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 168.29 201.07 259.20 289.81 312.06

Competitive Comparison of MedCap AB's Median PS Value

For the Medical Devices subindustry, MedCap AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where MedCap AB's Price-to-Median-PS-Value falls into.


;
;

MedCap AB Median PS Value Calculation

MedCap AB's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=121.13*2.5762
=312.06

10-Year Median PS Ratio is 2.5762.
MedCap AB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr121.13.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedCap AB  (OSTO:MCAP) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

MedCap AB's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=340.00/312.06
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedCap AB Median PS Value Related Terms

Thank you for viewing the detailed overview of MedCap AB's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


MedCap AB Business Description

Traded in Other Exchanges
Address
Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.